keine Finanzberatung

PODD · Insulet Corporation

Maker of the Omnipod tubeless insulin patch pump

Risiko 6/10 · ELEVATED RISK · growth-reset medtech · $147.48 ▼ 2.06%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $147.48
  • Market cap $10.2B
  • P/E (ttm) 27.62
  • Div yield none
  • 52-wk range $126.40 – $354.88
  • Index rank #472 / —

Wichtigste Risiken

  • GLP-1 drugs shrinking the addressable pump market (Shareholders) — HIGH
  • Growth reset: sales-outlook cut and downgrade wave (Shareholders) — HIGH
  • Competition from Tandem, Medtronic and patch entrants (Shareholders) — MED
  • Device reliability and recall risk (Patients) — MED

Fazit

Great product, cracked narrative — cheap versus its own history only if diabetes-device growth survives the GLP-1 era.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.